The long noncoding RNA nuclear-enriched abundant transcript 1 (NEAT1) is reportedly involved in the initiation and progression of cancers of several types.
A nuclear-restricted lncRNA, nuclear paraspeckle assembly transcript 1 (NEAT1), encodes two transcriptional variants, NEAT1-1 and NEAT1-2, of lengths 3756 and 22 743 bp, respectively. 11 NEAT1 participates in several processes, including differentiation of cells, 12 inflammation 13 and stress responses. 14 Mounting evidence indicate that NEAT1 plays key part in tumor initiation and progression in cancers, including breast cancer, 15 colorectal cancer, 16 non-small cell lung cancer, 17, 18 cervical carcinoma, 19 hepatocellular carcinoma, 20 osteosarcoma, 21 nasopharyngeal carcinoma, 22 oral squamous cell carcinoma cells, 23 ovarian cancer 24 and esophageal squamous cell carcinoma. 15 However, more studies are needed to assess the effects of NEAT1 on RB in terms of biological function and the intrinsic mechanisms. Therefore, this study evaluated the expression levels, function, and the mechanism of NEAT1 activity in RB. We sought to examine the difference in expression of NEAT1 between RB tissues and normal retina tissues. We further investigated in vitro, the effect of the NEAT1 on RB-affected cells, including the progression of the cell cycle, multiplication, and apoptosis. This study also aims to enhance the knowledge base to discern the RB progression and its mechanism.
| MATERIALS AND METHODS

| Tissue sample collection
The Ophthalmology Department in the Second Hospital of Jilin University (Changchun, China) provided us with 32 freshly frozen tissue samples of retinoblastoma and eight tissues samples of normal retina specimens. 8 The normal retina tissue samples were obtained from ruptured globes. All clinical specimens were obtained from enucleated eyes and flash frozen in liquid N 2 until use. None of the patients received chemotherapy or local radiotherapy before surgery. This study was carried out as per the Declaration of Helsinki, after acceptance from the Committee of Research Ethics in Second Hospital of Jilin University. Each patient or their parents were informed and their written consent was acquired.
| Assays with cultured cells
Three human RB cell lines Y79, WERI-Rb1, and SO-RB-50 ARPE-19, the epithelial retina cells of human, were purchased from ATCC (Manassas, VA). Each cell line was grown at 37°C in the medium (RPMI-1640) augmented with 10% fetal bovine serum (both from Gibco, Carlsbad, CA) and antibiotic streptomycin/penicillin (1%; Invitrogen, Waltham, MA) in an atmosphere containing appropriate humidity and 5% CO 2 .
| Cell transfection
To assess downregulation of NEAT1, three small interference RNAs (siRNAs), si-NEAT1#1, #2, and #3 targeting human NEAT1 and its negative control nonsense sequence (si-NC) were designed and synthesized by GenePharma (Shanghai, China). The miR-124 inhibitors, its negative control (anti-miR-124), mimics of miR-124 and miR-NCs (respective negative controls) were brought from Genecopoeia (Guangzhou, China). Y79 cells were transfected for 48 hours with 50 μM of siRNA or 100 nM miR-124 mimic or inhibitor along with Lipofectamine 2000 (Invitrogen), and the efficiency of transfection was evaluated by quantitative real-time polymerase chain reaction (qRT-PCR).
| The qRT-PCR assay
The tissue samples were used for isolating total RNA using the TRIzol reagent (Invitrogen). The total amount and quality of RNA were assessed and for each sample, 1 μg RNA was used for cDNA first strand synthesis with the PrimeScript reverse transcription reagent Kit procured from Takara (Dalian, China), then quantified using SYBR Premix Ex Taq™II (Takara) on a 7500 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA). The endogenous controls were U6 and glyceraldehyde 3-phosphate dehydrogenase for normalization to miR-124 and NEAT1, respectively. The primers used in this study are mentioned ( Table 1 ). The relative gene expression level was determined using the 2 C −ΔΔ t formula on ABI software, Foster City, CA. specified time (24, 48 and 72 hours), 100 μL of fresh medium with 10% CCK-8 solution was added after removing an equal volume of spent medium, and further maintained at 37°C for 4 hours. Then, the absorbance was detected at 450 nm on an ELISA plate reader (Thermo Labsystems, Helsinki, Finland).
| Cell proliferation assay
| Flow cytometry assay to detect cell cycle arrest
After 48 hours of transfection, the collected cells were centrifuged and suspended again in the binding buffer for assessing the stage of the cell cycle. Using propidium iodide (PI; Beijing Solarbio Science & Technology Co, Ltd, Beijing, China), the cells were stained in the presence of RNase A for 15 minutes. Finally, cell cycle arrest was flow-cytometrically assessed using BDLSR II from BD Biosciences (Franklin Lakes, NJ), and was evaluated using CellQuest 3.0 software (BD Biosciences).
| Apoptosis detection
Cells were collected 48 hours posttransfection and were observed using the Apoptosis Detection Kit Annexin V-FITC (BD Biosciences), under a flow cytometer (Becton Dickinson, San Jose, CA) as per manufacturer's instruction. The percentage of cell apoptosis was determined using CellQuest 3.0 software (Becton Dickinson).
| Assay to determine caspase-3/9 activities
The caspase-3/9 activities were measured using Assay Kit AAT-22820 (Beyotime Institute of Biotechnology, Beijing, China) as per protocol specified by the manufacturer. The absorbance (405 nm) was measured using a microplate reader (BioTek Instruments, Inc, Winooski, VT) to determine caspase-3/9 activities.
| The RNA immunoprecipitation assay
The RNA immunoprecipitation (RIP) assay was performed using the RNA-Binding Protein Immunoprecipitation Kit (Merck Millipore, Billerica, MA) as per the instructions of the manufacturer. After RIP, qRT-PCR was done to assess NEAT1 expression as described. 
| Dual fluorescence assay
| Statistical analyses
All results were determined from the experiments that were repeated three times independently and showed as the mean ± SD (standard deviation). SPSS v. 19.0 (IBM Corp, Armonk, NY) was used for all analyses. The Student t test and one-way analysis of variance with Tukey's post-hoc test were applied to compare among two groups and more than two groups, respectively. The relationship of NEAT1 with miR-124 was assessed through Spearman's correlation analysis after accounting for the statistically significant difference (P < 0.05).
3 | RESULTS
| Upregulation of NEAT1 in RB-affected tissues and cell lines
When the NEAT1 expression levels in 32 RB-affected tissues and eight normal retina tissues were assessed by qRT-PCR, the results show that the RB tissues have significantly higher NEAT1 expression than that in normal retinal tissues ( Figure 1A) . Subsequently, the NEAT1 expression level in three RB cell lines Y79, WERI-Rb1, and SO-RB-50) and in epithelial cells of the human retina, ARPE-19 was evaluated ( Figure 1B) . The three RB cell lines, in comparison to the ARPE-19 cells, showed significantly upregulated NEAT1 (P < 0.01). Thus, the genesis of RB may involve the participation of NEAT1.
3.2 | Knockdown of NEAT1 leads to inhibition of proliferation of RB cell and cell cycle procession
To assess the role of NEAT1 in RB cells, the NEAT1 was knocked down using the siRNA against NEAT1, si-NEAT1#1, si-NEAT1#2, and si-NEAT1#3 in Y79 cells. The qRT-PCR results revealed that the transfection of Y79 cells with the three siRNAs had a notably reduced NEAT1 expression as compared with its levels in the si-NC-transfected cells (Figure 2A) . The most remarkable effect on NEAT1 expression (81% reduction) was observed through the use of si-NEAT1#2, as confirmed in Figure 1A . Therefore, si-NEAT1#2 was selected as the best candidate siRNA for all below studies and was named as si-NEAT1. In addition, the knockdown of NEAT1 in Y79 cells significantly reduced their viability as observed through the CCK-8 assay ( Figure 2B ). To examine the mechanisms and the role of NEAT1 on the of RB cell proliferation, the cell cycle arrest was flow-cytometrically assessed. The results revealed that NEAT1 knockdown in Y79 cells increased the arrest of the cell cycle at G0/G1 phase and reduced at the S phase ( Figure 2D ). Thus, in the Y79 cells, NEAT1 knockdown impeded cell proliferation by regulating cell cycle procession.
| NEAT1 knockdown induces RB cell apoptosis
The effect of LINC00152 knockdown on the Y79 cell apoptosis was then explored by flow cemetery analysis. As shown in Figure 3A , a remarkable induction in apoptosis in Y79 cells (P < 0.01) is observed due to the knockdown of NEAT1. To examine the inherent mechanism of NEAT1 effect cell apoptosis, the activities of caspase-3 and -9 were examined, which were found to be increased notably in the si-NEAT1-transfected Y79 cells compared with si-NC-transfected cells ( Figure 3B and 3C ).
| miR-124 expression is directly regulated by NEAT1
LncRNAs reportedly affect the expression of miRNA by acting as a competitive endogenous RNA (ceRNA), thereby influencing tumor progression. 25 To identify the NEAT1 target miRNAs in RB cells, we used a target prediction tool Starbase 2.0, and selected miR-124 as a probable target ( Figure 4A ) based on its role in regulating tumor progression. 26 To confirm this prediction, we carried out luciferase assay and revealed that a significant reduction in the WT-NEAT1 luciferase activity but not that of MT-NEAT1 ( Figure 4B ; P < 0.05) as a result of miR-124 overexpression. Moreover, RIP assay confirmed that both NEAT1 and miR-124 were enriched in pulled down Ago2 protein in Y79 cells ( Figure 4C ), indicating that NEAT1 could act as a miR-124 sponge in RB cells. Concurrently, we found that NEAT1 downregulation in Y79 cells significantly enhanced the miR-124 levels ( Figure 4D ; P < 0.05), and that mimics of miR-124 remarkably reduced NEAT1 expression in Y79 cells, while miR-124 inhibitor obviously increased NEAT1 expression in Y79 cells ( Figure 4E ; P > 0.05). In addition, the miR-124 was remarkably down-expressed in Figure 4H ) was observed, indicating that NEAT1 may reduce miR-124 availability by binding directly to the latter.
| miR-124 inhibition restores the inhibitory effects of NEAT1 knockdown on RB cells
To assess if NEAT1 exerts an oncogenic effect on RB cells via miR-124, we performed a loss-of-function experiment and inhibited miR-124 expression in Y79 cells with NEAT1 knockdown (Figure 4A ). We found that miR-124 inhibitor reversed the effect of NEAT1 depletion on cell proliferation, cycle arrest, apoptosis and caspase-3 and -9 activities ( Figure 5B-F) . These results imply that NEAT1 exerts its biological function in RB cells by partially regulating miR-124.
| DISCUSSION
Recently, several lncRNAs have been implicated in the onset and progression of cancers, including RB, and serve as diagnostic markers and therapeutic target for RB. For instance, Hu et al 21 found that enhanced expression of XIST associates positively with an advanced stage of cTNM (III-V), its late differentiation status, and that XIST promoted RB cell proliferation and decreased cell apoptosis via sponging miR-124. Likewise, Yang et al 27 reported aggravated RB through highly expressed HOTAIR by regulating miR-613/c-met axis and implied HOTAIR as a promising biomarker to be used in diagnostics and as a target for RB therapy. Bi et al 28 showed the putative tumor-suppressor role of MT1JP by negatively modulating the action of the Wnt/β-catenin signaling pathway in the development of RB and that it may also be used as a prognostic biomarker and therapeutic target. Later, Li et al 29 showed that LINC00152 knockdown significant impeded cellular activities associated with perpetuation, enhanced cell apoptosis and caspase-3 and -9 activities in vitro, as well as suppressed tumorigenesis in vivo . In this study, we found increased expression of NEAT1 in RB-affected tissues and cell lines. We also showed that NEAT1 knockdown impeded RB cell proliferation, cycle procession, and induced apoptosis through repression of miR-124 expression by acting as a ceRNA. Hence, NEAT1 is a strong contender to act as a potential target for RB. The expression of NEAT1 is upregulated and it functions as an oncogenic lncRNA in many human malignant cancers. However, its expression status, function, and mechanism of action in RB need to be unraveled. The current study is the first to our knowledge that has investigated NEAT1 function and mechanism of its action in RB. We first revealed that NEAT1 expression is upregulated in RB-affected tissues and cell lines, and subsequently found that the knockdown of NEAT1 in RB cells remarkably inhibited cell proliferation, cycle progression, and promoted apoptosis, and caspase-3 and -9 activities. These findings suggested an oncogenic role of NEAT1 in RB tumorigenesis.
LncRNAs functions as a ceRNA by harboring binding sites for miRNAs and decreasing miRNA expression.
25
NEAT1 can act as ceRNAs for multiple miRNAs, such as miR-196-5p, 16 miR-211, 29 miR-384, 30 miR-342-3p, 31 miR-506, 32 and miR-9-5p. 33 Therefore, we used the software StarBase2.0 (http://starbase.sysu.edu.cn) to search for miRNAs that could target NEAT1. Among miRNAs, miR-124 was predicted as a target miRNA of NEAT1 based on its roles in RB. Studies report the downregulation of miR-124 and its role as a tumor suppressor in several kinds of cancers including RB. 22 Here, we confirmed through luciferase and RIP assays that NEAT1 indeed acts as a miR-124 sponge in RB cells. We also found that NEAT1 downregulation remarkably enhances miR-124 levels and that miR-124 mimics significantly decrease NEAT1 expression, while inhibitor of miR-124 obviously increased NEAT1 expression in Y79 cells. In addition, the miR-124 expression is inversely related to the NEAT1 expression and was observed to be significantly downregulated in RB tissues and cells. Importantly, we also found that miR-124 inhibitor reversed the effect of NEAT1 depletion on cell proliferation, cycle arrest, apoptosis and caspase-3 and -9 activities. These results imply that NEAT1 exerts its role in RB cells by partially regulating miR-124.
To conclude, the present study illustrates the oncogenic role of NEAT1 like that of an lncRNA to facilitate the tumorigenesis and RB progression by binding to miR-124 competitively and suggest the potential of NEAT1 as a target for RB therapy. Since NEAT1 could regulate multiple miRNA or other target genes, thus, the F I G U R E 5 miR-124 inhibition restores the inhibitory effects of NEAT1 knockdown on RB cells. A, Expression of miR-124 was examined in Y79 cells after transfection with si-NC and si-NEAT1 with (or without) the miR-124 inhibitor(anti-miR-124). B-F, Cell proliferation, cycle arrest, apoptosis, caspase-3 and -9 activities were determined in Y79 cells after transfection with si-NC and si-NEAT1 with (or without) the anti-miR-124. *P < 0.05 and **P < 0.01. miR-124, microRNA-124; NEAT1, nuclear-enriched abundant transcript 1; RB, retinoblastoma
